Sai Capital Limited has submitted a regulatory disclosure to BSE Limited regarding a key managerial personnel appointment at its material subsidiary, Butterfly Ayurveda Private Limited.
The disclosure is made under Regulation 30(9) read with Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and references SEBI Master Circular vide HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026.
The Board of Directors of Butterfly Ayurveda Private Limited, at their meeting held on May 28, 2026, approved the appointment of Ms. Anjali Pattanayak (ACS Membership No.: A75339) as the Company Secretary and Key Managerial Personnel of the subsidiary. The appointment is effective immediately.
Ms. Pattanayak is an Associate Member of the Institute of Company Secretaries of India (ICSI) with professional experience in Secretarial Affairs, Corporate Governance, and Statutory Compliances.
The disclosure includes an annexure (Annexure-A) providing requisite details as required by Regulation 30. The annexure specifies:
- Reason for change: Appointment of Company Secretary
- Date of Appointment: May 28, 2026
- Term of Appointment: Not Applicable
- Brief Profile: Ms. Anjali Pattanayak's qualifications and experience
- Disclosure of relationships between directors: Not Applicable
The document is signed by Dr. Niraj Kumar Singh, Chairman & Managing Director of Sai Capital Limited, and includes digital signature verification with timestamp of May 28, 2026, at 16:57:10 +05'30'.
Financial impact of this appointment is not quantified in the disclosure.